News

Clinical Trials Arena7m

Vendanta’s culls UC microbiome therapy on Phase II fail

Vendanta's CEO also announced the company is cutting 20% of its workforce as a result of the Phase II UC trial failure.
Pharmaceutical Commerce52m

Pharma Pulse: AbbVie Boosts Domestic API Manufacturing, Supermarkets Lead in Pharmacy Satisfaction, and GLP-1 Coverage Tightens

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...